Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
How Does Semaglutide Work? The Mechanism Explained
articleSemaglutide mimics a natural gut hormone to reduce hunger, slow digestion, and signal the brain to stop eating. This article explains exactly how each mechanism works and why the weekly injection lasts all week.
Semaglutide for Type 2 Diabetes: Ozempic and Rybelsus Guide
articleSemaglutide (Ozempic, Rybelsus) is FDA-approved for type 2 diabetes. The SUSTAIN trial programme, SUSTAIN-6 cardiovascular benefit in T2D patients, dosing, and how it differs from the weight-loss brand Wegovy.
What Is Semaglutide? GLP-1 Drug Guide (Ozempic, Wegovy)
articleSemaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It's the active ingredient in Ozempic, Rybelsus, and Wegovy. This guide explains what it is, how it works, what the clinical trials show, and who qualifies for treatment.